Tadarise Pro represents a significant advancement in the pharmacological management of erectile dysfunction (ED), combining the proven efficacy of Tadalafil with a strategically engineered delivery system. This formulation is designed for men seeking a reliable, long-lasting solution that supports spontaneity and restores confidence. Its unique pro version offers enhanced bioavailability, ensuring a more consistent therapeutic response. This product card provides a comprehensive, expert-level overview for healthcare professionals and informed patients, detailing its mechanism, appropriate use, and essential safety information.

Features

• Active Pharmaceutical Ingredient (API): Tadalafil 20 mg
• Pharmacological Class: Phosphodiesterase type 5 (PDE5) inhibitor
• Formulation: Oro-dispersible tablet
• Time to Onset: Approximately 30-45 minutes
• Duration of Effect: Up to 36 hours
• Bioavailability: Enhanced absorption profile compared to standard Tadalafil formulations
• Excipients: Includes mannitol, crospovidone, aspartame, and peppermint flavor

Benefits

• Provides a prolonged therapeutic window of up to 36 hours, reducing time-sensitive pressure and supporting natural sexual spontaneity.
• The oro-dispersible formulation allows for administration without water, offering discretion and convenience.
• Enhances blood flow to the corpus cavernosum, facilitating firm and reliable erections sufficient for sexual activity.
• Improved bioavailability ensures a more predictable and consistent response across diverse patient populations.
• Supports psychological confidence by reducing performance anxiety associated with erectile dysfunction.
• May improve overall quality of life and intimate relationship satisfaction.

Common use

Tadarise Pro is indicated for the treatment of erectile dysfunction in adult males. It is suitable for patients who desire an extended duration of action, allowing for greater flexibility in timing sexual activity. It is not intended for use by women, adolescents, or men without erectile dysfunction. The medication requires sexual stimulation to be effective and does not increase libido. It is commonly prescribed for both occasional and regular use, depending on the patient’s needs and physician recommendation.

Dosage and direction

The recommended dose is one tablet (20 mg) taken orally, approximately 30-45 minutes before anticipated sexual activity. The tablet should be placed on the tongue, where it will disperse rapidly without the need for water. Do not crush or chew the tablet. The dosage should not exceed one tablet in a 24-hour period. For some patients, particularly those with renal or hepatic impairment, a lower dose may be recommended. Efficacy may be reduced if taken with a high-fat meal. Always follow the prescribing physician’s instructions regarding dosage and frequency.

Precautions

• Prior to initiation, a thorough medical evaluation should be conducted to diagnose erectile dysfunction and identify underlying causes.
• Use with caution in patients with cardiovascular disease; sexual activity poses a potential cardiac risk, especially in those with pre-existing conditions.
• Not recommended for patients with severe hepatic impairment (Child-Pugh Class C) or severe renal impairment (creatinine clearance <30 mL/min).
• Avoid concomitant use with other PDE5 inhibitors or treatments for pulmonary arterial hypertension.
• May cause hypotension; caution is advised in patients taking antihypertensive medications.
• Patients with anatomical deformation of the penis (e.g., Peyronie’s disease) or conditions predisposing to priapism (e.g., sickle cell anemia) should use under close supervision.
• Contains aspartame; caution in patients with phenylketonuria.

Contraindications

• Hypersensitivity to Tadalafil or any excipients in the formulation.
• Concurrent administration of organic nitrates or nitric oxide donors (e.g., nitroglycerin, isosorbide mononitrate) in any form.
• Patients with a history of non-arteritic anterior ischemic optic neuropathy (NAION).
• Severe cardiovascular disorders where sexual activity is not advised.
• Concomitant use with guanylate cyclase stimulators such as riociguat.

Possible side effects

• Common (≥1/100 to <1/10): Headache, dyspepsia, back pain, myalgia, nasal congestion, flushing.
• Uncommon (≥1/1,000 to <1/100): Dizziness, visual disturbances, gastroesophageal reflux, palpitations.
• Rare (<1/1,000): Priapism (prolonged and painful erection lasting more than 4 hours), sudden hearing loss, hypotension, syncope.
• Very rare: Non-arteritic anterior ischemic optic neuropathy (NAION), seizures, serious cardiovascular events. Patients should seek immediate medical attention if an erection lasts more than 4 hours or if sudden vision or hearing loss occurs.

Drug interaction

• Nitrates: Concomitant use is contraindicated due to risk of severe hypotension.
• Alpha-blockers: May potentiate hypotensive effects; co-administration requires careful dose titration and monitoring.
• Antihypertensives: Additive blood pressure-lowering effects possible.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): May increase Tadalafil exposure; dose reduction recommended.
• Inducers of CYP3A4 (e.g., rifampin): May decrease Tadalafil efficacy.
• Alcohol: Excessive consumption may increase risk of orthostatic hypotension and dizziness.

Missed dose

Tadarise Pro is taken on an as-needed basis; there is no scheduled dosing regimen. If a dose is missed, it may be taken when remembered, provided it is at least 24 hours before the next anticipated dose. Do not double the dose to make up for a missed one.

Overdose

In case of suspected overdose, standard supportive measures should be employed. Expected effects may include severe headache, dizziness, flushing, dyspepsia, and hypotension. Hemodialysis is not expected to significantly accelerate clearance due to high protein binding. Management should focus on symptomatic treatment; in cases of severe hypotension, active cardiovascular support may be necessary.

Storage

Store below 30°C (86°F) in a dry place, protected from light and moisture. Keep in the original blister pack until use to maintain stability. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.

Disclaimer

This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new medication or changing an existing treatment plan. Do not disregard professional medical advice or delay seeking it based on information provided here. The manufacturer and distributor are not liable for any adverse outcomes resulting from the use or misuse of this product.

Reviews

“After struggling with ED for years, Tadarise Pro has been a game-changer. The 36-hour window eliminates timing anxiety, and the quick-dissolve tablet is incredibly convenient. My urologist recommended it, and I’ve experienced consistent results with minimal side effects.” – Mark T., 54

“As a prescribing physician, I find Tadarise Pro offers a reliable option for patients seeking longer duration. The enhanced bioavailability provides a more uniform response, and patient satisfaction rates in my practice have been notably high. Appropriate patient selection and counseling remain crucial.” – Dr. Evelyn Reed, Urologist

“I was initially hesitant, but the discreet administration and prolonged effect have restored confidence in my relationship. Mild flushing occurred the first time, but it subsided quickly. Highly recommend discussing with your doctor to see if it’s right for you.” – James L., 48